Apotex Strengthens Commitment to Women’s Health with Exclusive Canadian Rights to “Linzagolix” for Uterine Fibroid Treatment Women's Health Apotex Strengthens Commitment to Women’s Health with Exclusive Canadian Rights to “Linzagolix” for Uterine Fibroid Treatment admin October 10, 2025 0 TORONTO, Oct. 7, 2025 /CNW/ – Searchlight Pharma Inc.(“Searchlight”), Apotex Inc’s (“Apotex”) Branded Medicines... Read More Read more about Apotex Strengthens Commitment to Women’s Health with Exclusive Canadian Rights to “Linzagolix” for Uterine Fibroid Treatment
